‘Hopeful milestone’: Health Canada approves 2nd drug to slow Alzheimer’s – National | Globalnews.ca
This is the second disease-slowing drug for Alzheimer’s that has been approved in Canada, after Health Canada approved lecanemab, commercial
Global News







